Cleerly ISCHEMIA vs Zio XT ECG Monitoring System
AI Verdict
Choose Cleerly ISCHEMIA if…
Choose Cleerly ISCHEMIA if you need a non-invasive, detailed assessment of coronary artery disease, including plaque characterization, stenosis severity, and the likelihood of vessel-level ischemia, based on CCTA scans. This tool is ideal for physicians aiming to personalize diagnosis and treatment planning for heart disease patients through advanced AI-powered imaging analysis.
View Cleerly ISCHEMIA →Choose Zio XT ECG Monitoring System if…
Choose Zio XT ECG Monitoring System if you require continuous, long-term (up to 14 days) ambulatory cardiac monitoring for arrhythmia detection in patients experiencing symptoms like palpitations, shortness of breath, or dizziness, or for those who may be asymptomatic. This wearable, water-resistant biosensor is well-suited for improving diagnostic yield and patient compliance in detecting intermittent cardiac arrhythmias.
View Zio XT ECG Monitoring System →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Cleerly ISCHEMIA | Zio XT ECG Monitoring System |
|---|---|---|
| Pricing | Contact for details | Contact for pricing |
| Deployment | Web-based platform; data transfer via Cleerly Proxy (VPN or virtual appliance) | Cloud-based (AWS EC2 platform), no on-premise hardware required. |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | 1 AI-estimated | Yes AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Zio XT ECG Monitoring SystemZio XT offers superior patient usability due to its wearable, wire-free design that allows for normal daily activities, including showering, and boasts high patient compliance. Cleerly ISCHEMIA, while providing comprehensive reports, is a web-based platform analyzing CCTA scans, which inherently involves a more involved clinical procedure for the patient.
Clinical Value
TieBoth tools demonstrate significant clinical value within their respective domains. Cleerly ISCHEMIA provides non-invasive, vessel-level ischemia likelihood and plaque characterization from CCTA, validated in multiple trials to outperform or be equivalent to other noninvasive measures of ischemia. Zio XT offers continuous, long-term ECG monitoring with high diagnostic yield for arrhythmias, supported by studies showing improved diagnostic accuracy and reduced retesting compared to other ambulatory monitors.
Pricing & Value
TieBoth tools require contacting the company for specific pricing, indicating a lack of upfront transparency. However, both have established CPT codes for reimbursement, suggesting recognized value within the healthcare system.
Enterprise Readiness
Cleerly ISCHEMIACleerly ISCHEMIA is deployed as a web-based platform with data transfer via Cleerly Proxy (VPN or virtual appliance) and offers integration with PowerScribe via API, indicating a readiness for integration into existing radiology and cardiology workflows. Zio XT is cloud-based, but its primary interaction is through a physical device and a cloud platform for reporting, with less emphasis on direct EMR or PACS integration details in the provided information.
Innovation
TieBoth tools represent significant innovation in cardiac care. Cleerly ISCHEMIA utilizes AI to derive fractional flow reserve (FFR) estimation and detailed plaque characterization from standard CCTA scans, offering a non-invasive approach to ischemia detection. Zio XT innovates with its wearable, long-term, lead-free ECG biosensor and proprietary AI algorithm for arrhythmia detection, enhancing patient comfort and data collection over traditional methods.
Support & Docs
TieBoth companies indicate a commitment to support. Cleerly states they are 'committed to the success of our customers' and aim to solve challenges quickly. iRhythm provides a clinical reference manual and patient instructions, along with customer care contact information. Without more specific details on the breadth and depth of their support offerings (e.g., SLAs, training programs), it's difficult to definitively pick a winner.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Cleerly ISCHEMIA | Zio XT ECG Monitoring System |
|---|---|---|
| Tool Name | Cleerly ISCHEMIA | Zio XT ECG Monitoring System |
| Company | Cleerly | iRhythm Technologies |
| Description | FDA-cleared AI tool that analyzes CCTA scans to non-invasively determine the likelihood of coronary artery ischemia at a vessel level, aiding physicians in personalized diagnosis and treatment planning for heart disease. | Wearable, single-lead ECG biosensor for up to 14 days of continuous cardiac monitoring, utilizing FDA-cleared AI and expert review for accurate arrhythmia detection and diagnosis. |
| Key Features | AI-enabled CCTA analysis, Non-invasive fractional flow reserve (FFR) estimation, Vessel-level ischemia likelihood determination, Coronary plaque characterization (volume, type, location), Stenosis severity assessment, 3D digital models of coronary arteries, Comprehensive interactive web-based reports, Integration with PowerScribe via API | Wearable single-lead ECG biosensor (Zio biosensor), Continuous ambulatory cardiac monitoring for up to 14 days, Water-resistant design for normal daily activities, including showering, No external leads or wires for enhanced patient comfort and reduced artifacts, Proprietary, FDA-cleared deep-learned AI algorithm for ECG data analysis, Cloud-based software platform (ZEUS) for data storage, analysis, and reporting, Patient-activated button for symptomatic event logging, High patient compliance (up to 99%) and satisfaction |
| Specialties | Cardiology, Radiology | Cardiology, Emergency Medicine, Internal Medicine |
Videos
Demos, reviews, and walkthroughs featuring Cleerly ISCHEMIA and Zio XT ECG Monitoring System.
Frequently Asked Questions
More Comparisons
More matchups featuring Cleerly ISCHEMIA or Zio XT ECG Monitoring System
Backers
Who funded each tool's parent company.